Waypoint Orthopedics
Generated 5/9/2026
Executive Summary
Waypoint Orthopedics is a San Diego-based private medical device company founded in 2018, specializing in spine surgery innovation. Its flagship product, the Waypoint GPS (Guided Pedicle System), is a smart bone awl that provides real-time feedback to surgeons during pedicle cannulation, reducing radiation exposure and improving accuracy. The device addresses a critical unmet need in vertebral fixation, where screw misplacement can lead to complications. By integrating guidance directly into an existing surgical tool, Waypoint aims to enhance safety, efficiency, and surgeon confidence without disrupting workflow. The spine surgery market is large and growing, with increasing adoption of minimally invasive techniques. While still in early stages—lacking disclosed funding or regulatory clearances—the company's technology has strong potential to become a standard adjunct in pedicle access. Its value proposition is clear: reduced radiation, improved outcomes, and streamlined workflow. The primary near-term risk is regulatory and commercial execution. Overall, Waypoint Orthopedics presents a compelling but early-stage opportunity with a differentiated solution in a sizable market.
Upcoming Catalysts (preview)
- Q4 2026FDA 510(k) Clearance70% success
- Q1 2027First Clinical Publication60% success
- H2 2026Strategic Partnership with Spine Implant Manufacturer40% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)